期刊文献+

Wnt2 b和β-catenin在胃癌组织中的表达及临床意义? 被引量:1

Expression and Clinical Significance of Wnt2b and β-catenin in Gastric Carcinoma
下载PDF
导出
摘要 目的探讨 Wnt2 b和β-catenin在胃癌中的表达及其临床意义。方法采用免疫组织化学染色检测48例胃癌组织和48例癌旁正常组织中 Wnt2b和β-catenin的表达,并分析其临床意义。结果 Wnt2b 和β-cate-nin在胃癌组织中的表达率分别为81.3%、66.7%;显著高于癌旁正常组织(12.5%和0%),差异具有统计学意义(χ^2=45.553,P< 0.05);Wnt2b的表达与TNM分期、分化程度、淋巴结转移相关(P < 0.05);β-catenin的表达与TNM分期、分化程度、组织学类型、淋巴结转移和癌侵犯神经相关(P < 0.05);且 Wnt2 b 与β-catenin蛋白的表达呈显著正相关性(r=0.340,P< 0.05)。结论 Wnt2b和β-catenin在胃癌的进展、分化、浸润和转移中起重要作用,是判断胃癌生物学行为的良好指标。 Objective]To explore the expression and clinical significance of Wnt2b andβ-catenin in gastric carcino-ma.[Methods]The expressions of Wnt2b andβ-catenin in 48 gastric cancer tissues and 48 normal paracancerous tissues were detected by immunohistochemistry method.Clinical significance was analyzed.[Results]The expressions of Wnt2b andβ-catenin in gastric carcinoma tissues were 6 6 .7% and 3 5 .4% respectively,which were markedly higher than those in normal paracancerous tissues,and there were significant differences(χ2=45.553,P〈 0.05).The expression of Wnt2b was correlated with TNM stage,differentiation degree and lymph node metastasis(P〈 0.05).The positive expression ofβ-catenin in cancer tissues was obviously higher than that in normal paracancerous tissues(χ2=48.000,P〈 0.05),and correlated with TNM stage,differential degree,lymph node metastasis and nerve invasion(P〈 0.05).The protein ex-pression of Wnt2b was positively correlated with the protein expression ofβ-catenin(r=0.340,P〈 0.05).[Conclusion]Wnt2b andβ-catenin play important roles in the progression,differentiation,infiltration and lymph node metastasis of gastric carcinoma,and may be the good indicators for j udging the biological behavior of gastric carcinoma.
出处 《医学临床研究》 CAS 2014年第12期2297-2299,2302,共4页 Journal of Clinical Research
基金 湖南省医药卫生科研计划项目(编号:B2013-148) 湖南省教育厅科技项目(编号:14C0141)
关键词 蛋白质类 生长物质 钙黏着糖蛋白类 免疫组织化学 胃肿瘤/病理学 Proteins Growth Substances Cadherins Immunohistochemistry Stomach Neoplasms/PA
  • 相关文献

参考文献12

  • 1Jemal A, Bray F, Center MM, et al . Global cancer statistics [J]. CA Cancer J Clin, 2011,61(2) : 69-90.
  • 2Meyer H J, Wilke H. Treatment strategies in gastric cancer [J]. Dtsch Arztebl Int, 2011,108(41): 698-705.
  • 3Cai C, Zhu X. The Wnt/β-catenin pathway regulates self-re newal of cancer stem like cells in human gastric cancer[J]. Mol Med Report, 2012,5(5) : 1191- 1196.
  • 4Yan L, Della Coletta L, Powell KL, et al . Activation of the canonical Wnt/β catenin pathway in ATF3-induced mamma ry tumors[J]. PLoS One, 2011,6(1): e16515.
  • 5Herr P, Hausmann G,Basler K. WNT secretion and signalling in human disease [ J ]. Trends Mol Med , 2012, 18 ( 8 ) : 483 -493.
  • 6Katoh M. Wnt2b:Comparative integromics and clinical appli cations [J].Int J Mol Med, 2005,16(6) :1103- 1108.
  • 7Katoh M,Kirikoshi H,Terasaki H, et al . WNT2B2 mRNA, up regulated in primary gastric cancer, is a positive regulator of the WNT-beta-catenimTCF signaling pathway [J]. Biochem Biophys Res Cornmun, 2001, 289(5): 1093-1098.
  • 8Ogasawara N, Tsukamoto T, Mizoshita T, et al . Mutations and nuclear accumulation of beta-catenin correlate with intes- tinal phenotypic expression in human gastric cancer [J]. Histopathology, 2006, 49(6) :612-621.
  • 9Sereno M, Aquayo C, Guillen ponce C, et al . Gastric tumours in hereditary cancer syndromes: clinical features, molecularbiology and strategies for prevention[J]. World J Surg, 2011,13(9): 599-610.
  • 10Valenta T, Hausmann G, Basler K. The many faces and functions of β- eatenin[J]. EMBO J , 2012,31(12) : 2714- 2736.

二级参考文献16

  • 1Kanai F, Marignani PA, Sarbassova D, Yagi R, Hall RA, Donowitz M, Hisaminato A, Fujiwara T, Ito Y, Cantley LC, Yaffe MB. TAZ: a novel transcrip- tional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 2000; 19:6778-6791 [PMID: 11118213 DOh 10.1093/em- boj/19.24.6778].
  • 2Sudol M, Bork P, Einbond A, Kastury K, Druck T, Negrini M, Huebner K, Lehman D. Character- ization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel pro- tein module, the WW domain. J Biol Chem 1995; 270:14733-14741 [PMID: 7782338 DOI: 10.1074/ jbc.270.24.14733].
  • 3Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J 2012; 31:2714-2736 [PMID: 22617422 DOI: 10.1038/em- boj.2012.150].
  • 4de Cristofaro T, Di Palma T, Ferraro A, Corrado A, Lucci V, Franco R, Fusco A, Zannini M. TAZ/ WWTR1 is overexpressed in papillary thyroid carci- noma. EurJ Cancer 2011; 47:926-933 [PMID: 21131195 DOI: 10.1016/j.ejca.2010.11.008].
  • 5Chart SW, Lira CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 2008; 68:2592-2598 [PMID: 18413727 DOI: 10.1158/0008-5472.CAN-07-2696].
  • 6Chan SW, Lim CJ, Loo LS, Chong YF, Huang C, Hong W. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation. J Biol Chem 2009; 284:14347-14358 [PMID: 19324876 DOh 10.1074/jbc.M901568200].
  • 7Pan J, Li S, Chi P, Xu Z, Lu X, Huang Y. Lentivirus- mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell prolifera- tion in vitro and tumor growth in vivo. Oncol Rep 2012; 28:179-185 [PMID: 22470139 DOI: 10.3892/ or.2012.1751].
  • 8Yuen HF, McCrudden CM, Huang YH, Tham JM, Zhang X, Zeng Q, Zhang SD, Hong W. TAZ expres- sion as a prognostic indicator in colorectal cancer. PLoS One 2013; 8:e54211 [PM1D: 23372686 DOI: 10.1371/journal.pone.0054211].
  • 9Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY. Prognostic significance of TAZ expression in resected non-small cell lung cancer. J Thorac Oncol 2012; 7:799-807 [PMID: 22481233 DOI: 10.1097/JTO.0b013e318248240b].
  • 10Zhou Z, Hao Y, Liu N, Raptis L, Tsao MS, Yang X. TAZ is a novel oncogene in non-small cell lung can- cer. Oncogene 2011; 30:2181-2186 [PMID: 21258416 DOI: 10.1038/onc.2010.606].

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部